Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caspofungin in Japanese Children and Adolescents with Fungal Infections
NCT01165320Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jul 2010
- Primary completion
- Sep 2013
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
01
Overview
A Phase 2 trial of caspofungin in Esophageal Candidiasis, invasive candidiasis, aspergillosis, sponsored by Merck & Co.. Started Jul 2010; status: completed.
02
Drugs
caspofungin
03
Conditions
Esophageal Candidiasisinvasive candidiasisaspergillosis
Beyond the preview
Go deeper on NCT01165320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01165320.